Financial Survey: NeueHealth (NEUE) vs. Its Rivals

NeueHealth (NYSE:NEUE) is one of 14 public companies in the “Hospital & medical service plans” industry, but how does it weigh in compared to its competitors? We will compare NeueHealth to similar companies based on the strength of its valuation, risk, analyst recommendations, profitability, dividends, earnings and institutional ownership.

Insider and Institutional Ownership

63.9% of NeueHealth shares are owned by institutional investors. Comparatively, 80.4% of shares of all “Hospital & medical service plans” companies are owned by institutional investors. 64.3% of NeueHealth shares are owned by insiders. Comparatively, 10.2% of shares of all “Hospital & medical service plans” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares NeueHealth and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
NeueHealth	$1.16 billion	-$1.15 billion	-0.04
NeueHealth Competitors	$80.60 billion	$2.78 billion	9.54

NeueHealth’s competitors have higher revenue and earnings than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Volatility & Risk

NeueHealth has a beta of 0.84, indicating that its share price is 16% less volatile than the S&P 500. Comparatively, NeueHealth’s competitors have a beta of 0.95, indicating that their average share price is 5% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for NeueHealth and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeueHealth	0	1	0	0	2.00
NeueHealth Competitors	94	1117	2556	98	2.69

NeueHealth presently has a consensus price target of $8.00, suggesting a potential upside of 26.78%. As a group, “Hospital & medical service plans” companies have a potential upside of 15.58%. Given NeueHealth’s higher probable upside, equities research analysts plainly believe NeueHealth is more favorable than its competitors.

Profitability

This table compares NeueHealth and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeueHealth	-71.23%	N/A	-1.21%
NeueHealth Competitors	-0.12%	-1.59%	-0.02%

Summary

NeueHealth competitors beat NeueHealth on 10 of the 13 factors compared.

About NeueHealth

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.